Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Prince

Showing results (311-320 of 418) with videos related to

Pageof 42
Sort By:
The Lancet. Psychiatry|September 12, 2015
Care for bipolar disorder in LMICs needs evidence from local settingsAbebaw Fekadu, Charlotte Hanlon, Graham Thornicroft, et al.
Clinical Trials (London, England)|January 10, 2017
Healthy Children, Strong Families 2: A randomized controlled trial of a healthy lifestyle intervention for American Indian families designed using community-based approachesEmily J Tomayko, Ronald J Prince, Kate A Cronin, et al.
The Lancet. Psychiatry|May 18, 2019
Ethnic density and other neighbourhood associations for mortality in severe mental illness: a retrospective cohort study with multi-level analysis from an urbanised and ethnically diverse location in the UKJayati Das-Munshi, Peter Schofield, Vishal Bhavsar, et al.
BMC Public Health|April 16, 2011
Women in post-trafficking services in Moldova: diagnostic interviews over two time periods to assess returning women's mental healthNicolae V Ostrovschi, Martin J Prince, Cathy Zimmerman, et al.
Diabetes Care|June 27, 2013
Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147Richard M Bergenstal, Julio Rosenstock, Richard F Arakaki, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 studyT C Blevins, D Dahl, J Rosenstock, et al.
Diabetes Care|July 13, 2012
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetesRichard M Bergenstal, Julio Rosenstock, Richard F Arakaki, et al.
Sexually Transmitted Diseases|October 26, 2019
Repeat Episodes of Symptomatic Urethritis Due to a Uropathogenic Meningococcal CladeJose A Bazan, Yih-Ling Tzeng, David S Stephens, et al.
Current Topics in Medicinal Chemistry|May 25, 2006
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugsPaul M O'Neill, Stephen A Ward, Neil G Berry, et al.
Evolutionary Applications|April 7, 2022
Reduced relative fitness in hatchery-origin Pink Salmon in two streams in Prince William Sound, AlaskaKyle R Shedd, Emily A Lescak, Christopher Habicht, et al.
Pageof 42

Showing results (311-320 of 418) with videos related to

Sort By:
Pageof 42
The Lancet. Psychiatry|September 12, 2015
Care for bipolar disorder in LMICs needs evidence from local settingsAbebaw Fekadu, Charlotte Hanlon, Graham Thornicroft, et al.
Clinical Trials (London, England)|January 10, 2017
Healthy Children, Strong Families 2: A randomized controlled trial of a healthy lifestyle intervention for American Indian families designed using community-based approachesEmily J Tomayko, Ronald J Prince, Kate A Cronin, et al.
The Lancet. Psychiatry|May 18, 2019
Ethnic density and other neighbourhood associations for mortality in severe mental illness: a retrospective cohort study with multi-level analysis from an urbanised and ethnically diverse location in the UKJayati Das-Munshi, Peter Schofield, Vishal Bhavsar, et al.
BMC Public Health|April 16, 2011
Women in post-trafficking services in Moldova: diagnostic interviews over two time periods to assess returning women's mental healthNicolae V Ostrovschi, Martin J Prince, Cathy Zimmerman, et al.
Diabetes Care|June 27, 2013
Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147Richard M Bergenstal, Julio Rosenstock, Richard F Arakaki, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 studyT C Blevins, D Dahl, J Rosenstock, et al.
Diabetes Care|July 13, 2012
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetesRichard M Bergenstal, Julio Rosenstock, Richard F Arakaki, et al.
Sexually Transmitted Diseases|October 26, 2019
Repeat Episodes of Symptomatic Urethritis Due to a Uropathogenic Meningococcal CladeJose A Bazan, Yih-Ling Tzeng, David S Stephens, et al.
Current Topics in Medicinal Chemistry|May 25, 2006
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugsPaul M O'Neill, Stephen A Ward, Neil G Berry, et al.
Evolutionary Applications|April 7, 2022
Reduced relative fitness in hatchery-origin Pink Salmon in two streams in Prince William Sound, AlaskaKyle R Shedd, Emily A Lescak, Christopher Habicht, et al.
Pageof 42